Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Liman Qiu"'
Autor:
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiaolong Liu
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 5, Pp 1193-1219 (2024)
Abstract Radiotherapy (RT) has been reported to induce abscopal effect in advanced hepatocellular carcinoma (HCC), but such phenomenon was only observed in sporadic cases. Here, we demonstrated that subcutaneous administration of Toll-like receptor 3
Externí odkaz:
https://doaj.org/article/bcba5366feb043319a556460d8015150
Autor:
Geng Chen, Fang Peng, Xiuqing Dong, Zhixiong Cai, Zhenli Li, Lei He, Jinpan Hu, Xiaoxu Deng, Yutong Guo, Liman Qiu, Yang Zhou, Jingfeng Liu, Huqin Zhang, Xiaolong Liu
Publikováno v:
Molecular Oncology, Vol 17, Iss 9, Pp 1871-1883 (2023)
To overcome the dependency of strategies utilizing cell‐free DNA (cfDNA) on tissue sampling, the emergence of sequencing panels for non‐invasive mutation screening was promoted. However, cfDNA sequencing with panels still suffers from either inac
Externí odkaz:
https://doaj.org/article/0863433d1f6f49e4a4ace1601c1da413
Autor:
Lei He, Liman Qiu, Feng Chen, Tingting Chen, Fang Peng, Zhenli Li, Xiuqing Dong, Zhixiong Cai, Yuanchang Fang, Hengkai Chen, Geng Chen, Xiaolong Liu
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3578-3591 (2022)
Abstract CircRNAs have been reported to play crucial roles in tumor progression and recurrence, showing potential as biomarkers in cancer. However, the global abundance of circRNA and their involvement in hepatocellular carcinoma (HCC) development ha
Externí odkaz:
https://doaj.org/article/8610ca6fc9224649908793c174455622
Autor:
Xiuqing Dong, Geng Chen, Xinghui Huang, Zhenli Li, Fang Peng, Hengkai Chen, Yang Zhou, Lei He, Liman Qiu, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 1986-1999 (2022)
Transarterial chemoembolization (TACE) is the most commonly used treatment for advanced hepatocellular carcinoma (HCC), but still lacks accurate real‐time biomarkers for monitoring its therapeutic efficacy. Here, we explored whether copy number pro
Externí odkaz:
https://doaj.org/article/8893ad5754d04a2ba053f292c11a22e3
Autor:
Zhixiong Cai, Xiaoping Su, Liman Qiu, Zhenli Li, Xiaolou Li, Xiuqing Dong, Fuqun Wei, Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng, Xiaolong Liu
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background Clinically, prophylactic anti-recurrence treatments for hepatocellular carcinoma (HCC) patients after radical surgery are extremely limited. Neoantigen based vaccine can generate robust anti-tumor immune response in several solid
Externí odkaz:
https://doaj.org/article/79c94f7bdc2b4b8c90d4ebcaf5800121
Autor:
Yang Zhou, Zhenli Li, Geng Chen, Liman Qiu, Zhixiong Cai, Xiaolong Liu, Hengkai Chen, Xiuqing Dong, Yingjun Shi, Linsheng Cai, Wenhan Liu, Honghao Ye, Jiahe Ouyang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Personalized neoantigen vaccine could induce a robust antitumor immune response in multiple cancers, whose efficacy could be further enhanced by combining with programmed cell death 1 blockade (α-PD-1). However, the corresponding immune r
Externí odkaz:
https://doaj.org/article/8f26a61a30d745f1ace57bec32945f58
Autor:
Liman Qiu, Yanbing Huang, Zhenli Li, Xiuqing Dong, Geng Chen, Haipo Xu, Yongyi Zeng, Zhixiong Cai, Xiaolong Liu, Jingfeng Liu
Publikováno v:
Molecular Oncology, Vol 13, Iss 2, Pp 441-455 (2019)
Circular RNA (circRNA) can participate in various biological processes, including tumorigenesis, through their microRNA response elements. Alterations in circRNA profiles during hepatocellular carcinoma (HCC) progression and their clinical significan
Externí odkaz:
https://doaj.org/article/d86871785f4840ddb1db9f96f3ac955b
Autor:
Wei Zhang, Xiaoping Su, Yongyi Zeng, Zhenli Li, Youshi Zheng, Yingchao Wang, Geng Chen, Liman Qiu, Kun Ke, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Collecting duct carcinoma (CDC) of the kidney is a rare and highly aggressive malignant tumor with the worst prognosis among all renal cancers. Nevertheless, the first-line treatments, including chemotherapy and target therapy, usually sho
Externí odkaz:
https://doaj.org/article/d6a0e2e87c194aebb7cd1f726341c21d
Autor:
Xiuqing Dong, Geng Chen, Zhixiong Cai, Zhenli Li, Liman Qiu, Haipo Xu, Yuan Yuan, Xiao-Long Liu, Jingfeng Liu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 47, Iss 6, Pp 2602-2612 (2018)
Background/Aims: Aberrant RNA editing, mediated by adenosine deaminases acting on RNA (ADAR), serves as a post-transcriptional event participating in tumorigenesis and prognosis. However, the RNA editing profiles during HCC progression and their clin
Externí odkaz:
https://doaj.org/article/da484e619403407f8e509937efc354ef
Autor:
Zhenli Li, Geng Chen, Zhixiong Cai, Xiuqing Dong, Liman Qiu, Haipo Xu, Yongyi Zeng, Xiaolong Liu, Jingfeng Liu
Publikováno v:
OncoImmunology, Vol 8, Iss 2 (2019)
As key players in HCC antitumor response, the functions of tumor infiltrated CD8+ T cells are significantly affected by surrounding microenvironment. A detailed profiling of their genomic and transcriptional changes could provide valuable insights fo
Externí odkaz:
https://doaj.org/article/d042ef063c5b4c1d9a53bf8e5aa29f60